UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
February 11, 2020
Commission File Number: 001 - 38178
Zealand Pharma A/S
(Exact Name of Registrant as Specified in Its Charter)
Sydmarken 11
2860 Søborg (Copenhagen)
Denmark
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-Fx Form 40-F¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Furnished as Exhibit 99.1 to this Report on Form 6-K is a press release (“company announcement”) of Zealand Pharma A/S or the Company, dated February 11, 2020, announcing the receipt of a major shareholder notification from Wellington Management Group LLP.
Furnished as Exhibits 99.2 and 99.3 to this Report are the original notifications received from the shareholder.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | Zealand Pharma A/S |
| | | |
| | By: | /s/ Matthew Dallas |
| | | | |
| | | Name: | Matthew Dallas |
| | | Title: | Chief Financial Officer |
Date: February 11, 2020
EXHIBIT INDEX
Exhibit
No. | | Description |
| | | |
| 99.1 | | Press release dated February 11, 2020 |
| 99.2 | | Standard form for notification of major holdings for threshold crossed January 31, 2020 |
| 99.3 | | Standard form for notification of major holdings for threshold crossed February 4, 2020 |
